When was Helsinn founded?

Helsinn was founded in 1976 and raised its 1st funding round 47 years after it was founded.

Where is Helsinn located?

Helsinn is headquartered in Lugano, Switzerland. It is registered at Iselin, New Jersey.

How many employees does Helsinn have?

As of Sep 30, 2026, the latest employee count at Helsinn is 342.

Is Helsinn a funded company?

Helsinn is a funded company, having raised a total of $***** in its 1st and only funding round, a PE round on Jan 10, 2023.

When was the latest funding round of Helsinn?

Helsinn's latest funding was a $***** PE round on Jan 10, 2023, with participation from 1 investor.

Where does Helsinn rank among its competitors?

Helsinn ranks 74th amongst 1068 active competitors, of which 32 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Laboratorio Reig Jofre, which secured $14.7M in May, 2025.

Who are the top competitors of Helsinn?

Helsinn's top competitors include Teva Pharmaceuticals, The Alvogen and Laboratorio Reig Jofre. Among them, Laboratorio Reig Jofre secured the most recent funding round in May, 2025.

Helsinn - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of pharmaceutical products focused on cancer and chronic diseases. They operate an integrated licensing business model. The technical organization covers development, regulatory affairs, manufacturing, and supply chain. They focus on building brands globally through an extensive commercial and supply network. The business prioritizes the well-being of patients and society.

Website: helsinn.com
Social
Registered Address: Iselin, New Jersey

Key Metrics

Founded Year

1976

Location

Lugano, Switzerland

Stage

Late Stage

Latest Funding Round

PE, Jan 10, 2023, $*****

Investors

Oberland Capital

Ranked

74^th among 1068 active competitors

Employee Count

342 as on Sep 30, 2026

Investment & Acquisitions

AnaCardio & 4 more

Similar Companies

Enzon & 33 more

View Helsinn's full profile

Helsinn is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
HELSINN THERAPEUTICS U.S., INC CIN: 760640509 , United States, Active	Dec 31, 1999	-	41 (As on Dec 31, 2024)	-

Helsinn has raised funding over 1 round. Its latest funding round was a PE round on Jan 10, 2023 for $*****. 1 investor participated in its latest round. Helsinn has 1 institutional investor.

Here is the list of recent funding rounds of Helsinn:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 10, 2023	6460681	PE	7177371	3950869	3706212	8327404

Access funding benchmarks and valuations. Sign up today!

View details of Helsinn's funding rounds and investors

The founders of Helsinn is Gabriele Braglia.

Here are the details of Helsinn's key team members:

Gabriele Braglia: Founder of Helsinn.
Melanie Rolli: CEO of Helsinn.

Helsinn's Board of Directors

Helsinn's board has 17 active members. Riccardo Braglia, Paolo Ferrari, Melanie Rolli, Enrico Magnani, Matteo Santi, Roberta Cannella, Konrad Wilson, Alberto Antonini, Giulia Maria Valsecchi and Cristian Florin Muraru are part of team and Andrea Pontiggia, Antonella Bennici, Paolo Bottini, Riccardo Carbucicchio, Gabriele Edoardo Braglia, Jacques Maurice Eric Cornut and Enrico Baroni are independent board members.

Here is the list of Helsinn's board of directors:

Name	Type	Representing	Status	Duration
cqflibn	Team	-	Current	3y 8m
ijwswxx	Team	-	Current	9y 6m
yftuatb	Team	-	Current	9y 1m
utvkxvd	Team	-	Current	8y 2m
xkqfrut	Team	-	Current	2y 5m
xcurbmy	Team	-	Current	1y 6m
ufewxew	Team	-	Current	3y 5m
gpdbqvz	Team	-	Current	8y 6m
iwlqqha	Team	-	Current	4y 9m
kvgzqu{	Team	-	Current	6y 7m
Andrea Pontiggia	Independent board member	-	Current	-
cycqnyf	Independent board member	-	Current	4y 8m
zgwpiuh	Independent board member	-	Current	1y 9m
yqnyvrr	Independent board member	-	Current	8y 7m
yxsdmvj	Independent board member	-	Current	8y 1m
podjsfa	Independent board member	-	Current	2y 3m
twpfhcd	Independent board member	-	Current	1y 6m

View details of Helsinn's Founder profiles and Board Members

Helsinn's employee count trend

Helsinn has 342 employees as of Sep 26. Here is Helsinn's employee count trend over the years:

Uncover Helsinn's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Helsinn include Teva Pharmaceuticals, The Alvogen and Laboratorio Reig Jofre. Here is the list of Top 10 competitors of Helsinn, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
2nd	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Morgan Stanley, IMM Private Equity & 11 others	69/100
3rd	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
4th	Hikma Pharmaceuticals 1978, London (United Kingdom), Public	Manufacturer of generic medicines and injectable pharmaceutical products for patients	-	Tekla Capital Management, Foursan Group & 1 others	67/100
5th	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	JPMorganChase, Ampersand Capital & 4 others	66/100
6th	Otsuka 1921, Minato (Japan), Public	Manufacturer of generic pharmaceuticals and nutraceuticals	-	Digital Pharma Lab, Gates	66/100
7th	Takeda 1781, Tokyo (Japan), Public	Large diversified pharma company	-	Digital Pharma Lab, Kleiner Perkins & 8 others	66/100
8th	Bausch & Lomb 1853, Bridgewater (United States), Public	Manufacturer of prescription pharmaceutical products and various eye care items	-	Welsh, Carson, Anderson & Stowe, Thomas, McNerney & Partners ... & 2 others	65/100
9th	Dexcel 1965, Hadera (Israel), Unfunded	Developer and manufacturer of branded and generic pharmaceutical products	-	-	64/100
10th	Inventia Healthcare 1985, Mumbai (India), Acquired	Manufacturer & developer of various oral solid oral drug delivery systems	$42.5M	Nylim-jb Asset Management, Jacob Ballas Capital ... & 7 others	63/100
74th	Helsinn 1976, Lugano (Switzerland), Late Stage	Developer of pharmaceutical products focused on cancer and chronic diseases	-	Oberland Capital	51/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Helsinn's competitors? Click here to see the top ones

Helsinn has made 4 investments in companies including AnaCardio and Amal Therapeutics. Helsinn has also acquired 1 companies including Sapphire Therapeutics.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Sep 29, 2026	Investments	AnaCardio	2017	Sweden
Sep 05, 2017	Investments	Amal Therapeutics	2012	Geneva (Switzerland)
May 08, 2017	Investments	Aadi Bioscience	2008	Los Angeles (United States)